Located in the heart of Europe, Zentiva currently operates in 50 markets and reaches a target population of over one billion people.

15th Century

Zentiva’s roots trace back to one of the oldest pharmacies in Bohemia.

Zentiva’s origins can be traced back to the 15th Century Black Eagle pharmacy, or "U cerného orla", in Prague. It is one of the oldest in the Czech Republic.

Zentiva’s roots trace back to one of the oldest pharmacies in Bohemia
Zentiva’s roots trace back to one of the oldest pharmacies in Bohemia
 

1857

The Black Eagle pharmacy is purchased by the Fragner family.

The pharmacy was acquired by the Benjamin Fragner and his son Karel, who built a pharmaceutical plant on the outskirts of Prague. It was here that Zentiva’s current headquarters and production facilities were later built.

The Black Eagle pharmacy is purchased by the Fragner family.
The Black Eagle pharmacy is purchased by the Fragner family.
 

1930

The company’s first production of medicines in Prague.

The company starts production at a plant in a village called Dolní Mecholupy. It was aptly named the “Benjamin Fragner plant.”

The company’s first production of medicines in Prague
The company’s first production of medicines in Prague
 

Second World War

The plant becomes a sanctuary.

After closing of Czech universities at the height of World War II, the plant becomes, thanks to the efforts of the owner, a sanctuary to many prominent experts in the field of pharmacology and pharmaceutical research flourished.

The plant becomes a sanctuary
The plant becomes a sanctuary
 

1946

Zentiva is nationalized.

The government takes ownership of Zentiva and the plant at Dolní Mecholupy becomes part of SPOFA (United Pharmaceutical Works), who was led pharmaceutical production in Czechoslovakia at the time. The business had 750 employees.

Zentiva is nationalized
Zentiva is nationalized
 

1993

Léciva, the predecessor of Zentiva, is born.

Zentiva receives its first manufacturing practices certificate under the WHO standards for the production of antibiotics. Zentiva is the first manufacturer in the Czech Republic to receive certification.

The 70’s and 80’s

Extension, changes and improvements.

The expansion program was completed in 1979 and led to the construction of modern production facilities complete with state-of-the-art equipment. The new, enlarged plant resulted in a huge increase in production.

 
 

1998

Management buyout of Zentiva. The company begins to focus on branded generic medicines.

Zentiva management together with the private group, Warburg Pincus Funds, acquires majority shares in the company. This starts a new phase in the company’s development based on a branded generic medicines strategy. Investments are made in new facilities, research and development, and the company introduces a portfolio of modern and branded generic medicines.

2000

Implementation of new business processes and structures.

The firm delists from the Prague Stock Exchange (Burza cenných papíru Praha).

 
 

2003

Acquisition of Slovakofarma and the launch of the Zentiva corporate brand.

Zentiva begins its expansion into Central and Eastern Europe (Russia and Poland) and buys Slovakofarma, the leading pharmaceutical company in Slovakia. The Zentiva brand is now sold in Europe, Russia, Turkey, Africa and the Middle East.

Acquisition of Slovakofarma and the launch of the Zentiva corporate brand
Acquisition of Slovakofarma and the launch of the Zentiva corporate brand
 

2004

Zentiva lists on the Prague and London Stock Exchanges.

Zentiva becomes the first initial public offering (IPO) on the Prague Stock Exchange.

Zentiva lists on the Prague and London Stock Exchanges
Zentiva lists on the Prague and London Stock Exchanges
 

2005

Zentiva continues its regional expansion in Romania.

Zentiva acquires Sicomed, the leading generic medicine producer in Romania.

2006

Sanofi becomes Zentiva’s largest shareholder.

Sanofi claims 24.9% of Zentiva’s stock, becoming its largest shareholder.

 
 

2009

Full acquisition by Sanofi.

Sanofi takes full ownership of Zentiva and the latter becomes an important part of Sanofi’s strategy as a diversified global healthcare provider focusing on the needs of the patients.

2007

Zentiva further extends its geographic reach in Turkey.

Zentiva acquires Eczacibasi Generic Pharmaceuticals, a leading pharmaceutical company in Turkey.

 
 

2011

Sanofi launches Zentiva as a brand in Western Europe.

The Zentiva brand is launched in France, Italy, UK, Portugal and Germany.

News in the product portfolio
News in the product portfolio
 

2012

News in the product portfolio.

The Zentiva team coordinates the portfolio with new product development and regulatory processes.

News in the product portfolio
News in the product portfolio
 

2013

The Zentiva brand enters new markets.

Zentiva enters new markets in Africa and the Middle East.

Zentiva brand enters new markets
Zentiva brand enters new markets
 

Back to top